| Covasim: an agent-based model of COVID-19 dynamics and interventions CC Kerr, RM Stuart, D Mistry, RG Abeysuriya, K Rosenfeld, GR Hart, ... PLOS Computational Biology 17 (7), e1009149, 2021 | 738 | 2021 |
| Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality D Headey, R Heidkamp, S Osendarp, M Ruel, N Scott, R Black, M Shekar, ... The Lancet 396 (10250), 519-521, 2020 | 577 | 2020 |
| The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri, G Dusheiko, E Bugianesi, ... The Lancet 399 (10319), 61-116, 2022 | 476 | 2022 |
| The COVID-19 crisis will exacerbate maternal and child undernutrition and child mortality in low-and middle-income countries S Osendarp, JK Akuoku, RE Black, D Headey, M Ruel, N Scott, M Shekar, ... Nature food 2 (7), 476-484, 2021 | 226 | 2021 |
| Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model N Scott, ES McBryde, A Thompson, JS Doyle, ME Hellard Gut 66 (8), 1507-1515, 2017 | 180 | 2017 |
| Gender inequalities in health and wellbeing across the first two decades of life: an analysis of 40 low-income and middle-income countries in the Asia-Pacific region E Kennedy, G Binder, K Humphries-Waa, T Tidhar, K Cini, ... The Lancet Global Health 8 (12), e1473-e1488, 2020 | 158 | 2020 |
| Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade N Scott, JS Doyle, DP Wilson, A Wade, J Howell, A Pedrana, A Thompson, ... International Journal of Drug Policy 47, 107-116, 2017 | 152 | 2017 |
| Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care T Papaluca, L McDonald, A Craigie, A Gibson, P Desmond, D Wong, ... Journal of Hepatology 70 (5), 839-846, 2019 | 118 | 2019 |
| Outcomes of treatment for hepatitis C in primary care, compared to hospital-based care: a randomized, controlled trial in people who inject drugs AJ Wade, JS Doyle, E Gane, C Stedman, B Draper, D Iser, SK Roberts, ... Clinical Infectious Diseases 70 (9), 1900-1906, 2020 | 107 | 2020 |
| Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016–30 D Tordrup, Y Hutin, K Stenberg, JA Lauer, DW Hutton, M Toy, N Scott, ... The Lancet Global Health 7 (9), e1180-e1188, 2019 | 89 | 2019 |
| Modelling the impact of relaxing COVID‐19 control measures during a period of low viral transmission N Scott, A Palmer, D Delport, R Abeysuriya, RM Stuart, CC Kerr, D Mistry, ... Medical Journal of Australia 214 (2), 79-83, 2021 | 88* | 2021 |
| High‐frequency drug purity and price series as tools for explaining drug trends and harms in V ictoria, A ustralia N Scott, JP Caulkins, A Ritter, C Quinn, P Dietze Addiction 110 (1), 120-128, 2015 | 88 | 2015 |
| Gromov–Witten invariants of ℙ1 and Eynard–Orantin invariants P Norbury, N Scott Geometry & Topology 18 (4), 1865-1910, 2014 | 83 | 2014 |
| A global investment framework for the elimination of hepatitis B J Howell, A Pedrana, SE Schroeder, N Scott, L Aufegger, R Atun, ... Journal of hepatology 74 (3), 535-549, 2021 | 80 | 2021 |
| Australia needs to increase testing to achieve hepatitis C elimination N Scott, R Sacks‐Davis, AJ Wade, M Stoove, A Pedrana, JS Doyle, ... Medical Journal of Australia 212 (8), 365-370, 2020 | 77 | 2020 |
| Cost‐effectiveness of treating chronic hepatitis C virus with direct‐acting antivirals in people who inject drugs in Australia N Scott, DM Iser, AJ Thompson, JS Doyle, ME Hellard Journal of gastroenterology and hepatology 31 (4), 872-882, 2016 | 71 | 2016 |
| Ending malnutrition in all its forms requires scaling up proven nutrition interventions and much more: a 129-country analysis N Scott, D Delport, S Hainsworth, R Pearson, C Morgan, S Huang, ... BMC medicine 18, 1-19, 2020 | 68 | 2020 |
| Modelling the elimination of hepatitis C as a public health threat in Iceland: a goal attainable by 2020 N Scott, S Ólafsson, M Gottfreðsson, T Tyrfingsson, V Rúnarsdóttir, ... Journal of hepatology 68 (5), 932-939, 2018 | 68 | 2018 |
| The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments N Scott, E McBryde, P Vickerman, NK Martin, J Stone, H Drummer, ... BMC medicine 13, 1-12, 2015 | 67 | 2015 |
| Innovative strategies for the elimination of viral hepatitis at a national level: a country case series SE Schröeder, A Pedrana, N Scott, D Wilson, C Kuschel, L Aufegger, ... Liver International 39 (10), 1818-1836, 2019 | 65 | 2019 |
